Frontiers in Cardiovascular Medicine, 2022
Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis

Bracco Gartner T., Crnko S., Leiteris L. et al.

PLOS ONE, 2022
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease

Casselbrant A., Fedorowski A., Frantz S. et al.

Journal of Intensive Care, 2022
A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis

D’Onofrio V., Heylen D., Pusparum M. et al.

Scientific Reports, 2022
Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia

Junus K., Björk Ragnarsdóttir I., Nordlöf Callbo P. et al.

Cells, 2022
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy

Wang H., Davison M., Kramer M. et al.

Molecular Omics, 2022
Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients

Michels J., Nazrul M., Adhikari S. et al.

Cancers, 2022
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Gezelius E., Bendahl P., Gallo W. et al.

Diabetes, 2022
Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Ghanbari F., Yazdanpanah N., Yazdanpanah M. et al.

Life, 2022
Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart

Bhardwaj M., Schrotz-King P., Brenner H.

Journal of Internal Medicine, 2022
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

Arias de la Rosa I., López‐Montilla M., Román‐Rodríguez C. et al.

JACC: Basic to Translational Science, 2022
Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients

Kaye D., Nanayakkara S., Wang B. et al.

Neurotherapeutics, 2022
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

Simats A., Ramiro L., Valls R. et al.

Endocrine Connections, 2022
100 YEARS OF VITAMIN D: Combined hormonal contraceptives and vitamin D metabolism in adolescent girls

Öberg J., Jorde R., Figenschau Y. et al.

Frontiers in Cardiovascular Medicine, 2022
Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice

Kumawat A., Zegeye M., Paramel G. et al.

European Journal of Heart Failure, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

Ferreira J., Verdonschot J., Girerd N. et al.

Atherosclerosis, 2022
Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort

Rastogi T., Girerd N., Lamiral Z. et al.

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementia

Vromen E., del Campo Milán M., Scheltens P. et al.

International Journal of Molecular Sciences, 2022
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19

Costanzo M., Caterino M., Fedele R. et al.

British Journal of Dermatology, 2022
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Navrazhina K., Frew J., Grand D. et al.

Brain, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity

Ruck T., Barman S., Schulte-Mecklenbeck A. et al.